RDNT RadNet Inc.

RadNet’s Joint Venture, New Jersey Imaging Network, Acquires the Imaging Operations of Montclair Radiology, Expanding its Presence in New Jersey

RadNet’s Joint Venture, New Jersey Imaging Network, Acquires the Imaging Operations of Montclair Radiology, Expanding its Presence in New Jersey

LOS ANGELES, Oct. 11, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, today reported its joint venture, New Jersey Imaging Network (NJIN), has acquired the outpatient radiology assets of Montclair Radiology, the owner of six imaging centers in northern New Jersey.

For more than 75 years, Montclair Radiology has been a leading provider of diagnostic imaging in northern New Jersey, servicing an area encompassing a patient population of 16 million. Montclair Radiology owns and operates six multimodality centers in Montclair, West Caldwell, Nutley, Verona, Jersey City and Hoboken, providing MRI, CT, PET/CT, x-ray, ultrasound, mammography and other related procedures. Montclair Radiology performs over 200,000 procedures per year and is projected to add over $40 million of revenue on an annual basis to NJIN.

Dr. Howard Berger, Chairman and Chief Executive Officer of RadNet, noted, “We are pleased to announce this transaction. Since its formation in 2015, NJIN has grown into a leading provider of outpatient imaging in northern and central New Jersey, providing high-quality, lower cost and convenient services as an alternative to more expensive hospital-based imaging. Montclair Radiology’s long-standing brand has been a fixture in the markets it serves, and its high-quality reputation for delivering outstanding patient services is symbiotic with that of our existing NJIN operations.”

Dr. Michael Pollack, President of Montclair Radiology, shared, “The physicians and employees of Montclair Radiology are excited about this opportunity to affiliate with and become part of NJIN.  Our medical group has gained the trust of patients and referring physicians in northern New Jersey by providing exceptional radiology services.  NJIN and RadNet will provide the management and imaging expertise needed to grow our practice and to allow our physicians to focus on patient care.  We are confident that our employees will have a strong future with NJIN in this dynamically changing healthcare landscape.”

Montclair Radiology’s financial advisor was Ziegler and its legal advisor was Waller Lansden Dortch & Davis, LLP.

About RadNet, Inc.

RadNet, Inc., is the leading national provider of freestanding, fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 353 owned and/or operated outpatient imaging centers. RadNet's markets include Arizona, California, Delaware, Florida, Maryland, New Jersey and New York. Together with affiliated radiologists, inclusive of full-time and per diem employees and technicians, RadNet has a total of approximately 9,000 employees. For more information, visit .

About Ziegler

Ziegler is a privately held investment bank, capital markets and proprietary investments firm. Specializing in the healthcare, senior living and education sectors, as well as general municipal and structured finance, enables it to generate a positive impact on the communities it serves. Ziegler provides its clients with capital raising, strategic advisory services, equity and fixed income sales & trading and research. For more information, visit

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are expressions of our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Forward-looking statements in this press release include, among others, statements we make regarding response to and the expected future impacts of COVID-19, including statements about our anticipated business results, balance sheet and liquidity and our future liquidity, burn rate and our continuing ability to service or refinance our current indebtedness.

Forward-looking statements are neither historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue reliance on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements, including anticipated procedural volumes and revenue derived from the acquired Montclair Radiology assets.

Any forward-looking statement contained in this current report is based on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that we may make from time to time, whether as a result of changed circumstances, new information, future developments or otherwise, except as required by applicable law.

CONTACTS:

RadNet, Inc.

Mark Stolper, 310-445-2800

Executive Vice President and Chief Financial Officer



EN
11/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on RadNet Inc.

 PRESS RELEASE

RadNet, Inc. to Present at the Jefferies Healthcare Services Conferenc...

RadNet, Inc. to Present at the Jefferies Healthcare Services Conference on September 29, 2025 LOS ANGELES, Sept. 26, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Jefferies Healthcare Services Conference on Monday, September 29, 2025 at 1:50 p.m. C...

Radnet Inc: 1 director

A director at Radnet Inc sold 35,000 shares at 73.890USD and the significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

 PRESS RELEASE

RadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healt...

RadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025 LOS ANGELES, Sept. 08, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, Mark Stolper, Executive Vice President and Chief Financial Officer, and Mital Patel, Executive Vice President of Financial Planning & Analysis and Chief Admin...

 PRESS RELEASE

RadNet Reports Second Quarter Financial Results with Record Quarterly ...

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges Total Company Revenue increased 8.4% to a quarterly record of $498.2 million in the second quarter of 2025 from $459.7 million in the second quarter of 2024; Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 30.9% to a quarterly record of $20.7 million in the second quarter of 2025 from $15.8 million in the second quarter of 2024Total Company Adjusted EBITDA(1) was a quarterly record of $81.2 mill...

 PRESS RELEASE

DeepHealth, a RadNet Subsidiary, Receives FDA Clearance for Remote Sca...

DeepHealth, a RadNet Subsidiary, Receives FDA Clearance for Remote Scanning Solution, TechLive™ TechLive™ is a vendor-agnostic integrated solution enabling remote scanning of MR, CT, PET/CT, and Ultrasound procedures Amidst radiology technologist shortages, remote scanning in a command center configuration enables the workforce to scan at multiple locations simultaneously with a high level of expertiseRadNet has connected more than 300 MR, CT, PET/CT, and Ultrasound systems with TechLive™, delivering operational efficiency and increased access to advanced procedures LOS ANGELES and SOMERVI...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch